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Background/aim: Increased susceptibility to infections is a serious problem in diabetics. Impairment in the energy metabolism of the
immune system is the main source of the problem. Early diagnosis of the impairment in energy metabolism is crucial. Our study aimed
to investigate the energy metabolism in leukocytes in patient groups such as prediabetics and patients newly diagnosed with type 2
diabetes mellitus.
Materials and methods: Our study included 21 newly diagnosed type 2 diabetic patients (NDDP), 30 prediabetic patients, and 22 adult
volunteers. 75 g oral glucose tolerance test (OGTT) was applied to all patients included in the study. Blood samples were taken after 9-16
h of fasting and fasting blood glucose (FBG), postprandial blood glucose (PBG) levels, total cholesterol (TC), triglyceride (TG), highdensity lipoprotein (HDL), fasting serum insulin, and hemoglobin A1c (HbA1c) levels were evaluated. After the cells were completely
lysed, citrate levels from the released mononuclear leukocyte cells (MNC) content were manually studied, and lactate levels were applied
to the autoanalyzer with the lactate kit. Lactate and citrate results were calculated as µg/mL. Statistical comparisons were done using
Chi-square test, Mann-Whitney U test and student’s t test, and P < 0.05 values were accepted as significant.
Results: A significant difference was found between the controls and the other groups (newly diagnosed diabetic patients (NDDP),
impaired fasting glucose (IFG), and impaired glucose tolerance (IGT)) in terms of FBG levels (P < 0.001, P < 0.001 and P < 0.001,
respectively). IFG and IGT patients had significantly higher PBG levels compared to the control group (P = 0.009 and P < 0.001,
respectively). There was a significant difference between the IFG and IGT patients in terms of insulin levels (P = 0.019). There was a
significant relationship between FBG levels and lactate production only in the NDDP group (r = 0.610, P = 0.003)
Conclusion: The metabolic effects of hyperglycemia on leukocytes is in direction of anaerobic glycolysis. The increased anaerobic
pathway is closely related to blood glucose levels and insulin resistance.
Key words: Prediabetes, type 2 diabetes mellitus, intracellular energy, leukocyte

1. Introduction
Diabetes is a chronic metabolic disease where the
organism cannot make sufficient use of carbohydrates,
fats, and proteins due to insulin deficiency or defects in
insulin effectiveness requiring constant medical care [1].
Increased susceptibility to infections is a challenging
problem in diabetic patients. It has been shown that
a variety of mechanisms of innate immune system
are impaired in these patients. Lactate production is
considerably decreased in the neutrophils of diabetics,
whereas cytosolic calcium levels increase in neutrophils.
Chronic and persistent calcium entry into the cell occurs
and leads to inhibition of mitochondrial oxidation and
reduction in the amount of ATP [2-5]. Deterioration in the

energy metabolism of immune system plays a crucial role
in the development of infections [6].
Glucose can be used in glycolysis or oxidative
phosphorylation for the production of adenosine
triphosphate (ATP). Glycolysis occurs in the cytosol,
and 2 molecules of pyruvate are formed from 1 molecule
of glucose. 2 ATP is obtained from each molecule of
glucose and is oxygen independent. Pyruvate turns into
lactate. Alternatively, oxidative phosphorylation is oxygen
dependent and occurs in mitochondria. It consists of
two reactions: conversion of intermediate molecules
(pyruvate and fatty acid) to acetyl coenzyme A (Acetyl
CoA) and reduction of acetyl CoA to carbon dioxide
(CO2) in the tricarboxylic acid cycle. Net 30-32 ATP
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is earned for each glucose [7]. Citrate is a marker used
as an indicator of oxidative mechanism. In this case,
oxidative phosphorylation seems to be more efficient
in ATP production. Diabetic patients are known to be
susceptible to infections. One of the reasons for this
increased susceptibility to infections may be a decrease in
the oxidative mechanism, a decrease in the nonoxidative
mechanism, or a decrease in both mechanisms compared
to healthy volunteers [6].
The early diagnosis of the impairment in intracellular
energy metabolism in diabetic patients is extremely
important. Our study aimed to evaluate the levels of
aerobic and anaerobic oxidation products in leukocytes
of adult prediabetic and newly diagnosed type II diabetes
mellitus patients. The relationship between the severity
of diabetes and intracellular energy metabolism was also
investigated in our study.
2. Materials and methods
Written approval was obtained from the Local Ethics
Committee of the Faculty of Medicine in Kırıkkale
University on 28th April 2011 with the number 2011/0056.
Our study consisted of 21 newly diagnosed adult type II
diabetes patients and 30 prediabetic patients aged 19–70
years. Patients who applied to the endocrinology policlinic
of the Kırıkkale University Medical Faculty Hospital
during May 2011 were included in the study. None of
our patients were receiving diabetes control treatment.
The control group consisted of 22 adult volunteers who
were not morbidly obese or diabetic, and they were with
no additional disease and drug use. Volunteers who were
younger than 18 or older than 70 years, who were previously
diagnosed and treated diabetics, morbidly obese, who
had cardiovascular and cerebrovascular diseases or
organ insufficiency such as chronic renal insufficiency,
respiratory insufficiency and heart insufficiency, and who
received chemotherapy were excluded from the study.
Twenty-two volunteers (16 females and 6 males)
were included in the patients admitted to the outpatient
clinic. 75 g oral glucose tolerance test (OGTT) was applied
to all patients admitted to the outpatient clinic. The
patients were divided into 3 groups as healthy individuals,
prediabetics, and newly diagnosed type 2 diabetes mellitus
patients according to the OGTT results. Patients were
grouped as prediabetes (IFG: those with fasting plasma
glucose between 100-125 mg/dL and IGT: those with
second hour plasma glucose between 140-199 mg/dL in
OGTT), newly diagnosed diabetes (FBG = 126 mg/dL and
above and/or those with second hour blood glucose=200
mg/dL and above in OGTT) and healthy volunteers
according to the results of fasting blood glucose (FBG) and
OGTT 2nd h blood glucose. Blood samples were taken
after 9-16 h of fasting; FBG levels, total cholesterol (TC),

triglyceride (TG), high-density lipoprotein (HDL), fasting
serum insulin, and hemoglobin A1c (HbA1c) levels were
measured. The Olympus AU 400 auto-analyzer (Olympus
Corporation, Tokyo, Japan) was used with Olympus kits.
LDL level was measured using the Friedewal dequation
[LDL = TK - (VLDL + HDL); VLDL = TG / 5]. The HOMAIR calculation was used to determine insulin resistance.
The homeostasis model assessment (HOMA) insulin
resistance index (HOMA-IR) was calculated according to
the following formula: FBG (mmol / l) X fasting insulin
(μIU / mL) / 22.5.
The control samples of the study were taken from 22
volunteers who had no disease and fulfilled our control
group criteria. Samples were collected as approximately
7-8 mL venous blood into 9 mL BD Vacutainer tubes with
acid citrate dextrose (ACD). When the minimum target
number was reached, leukocyte samples were separated
from peripheral venous blood taken into ACD tubes by
Ficoll method; mononuclear leukocytes were isolated,
and fetal heart serum (fetal bovine serum) was added to
all samples equally and frozen at -80 ºC to maintain cell
viability.
The control group was prepared with the same
protocol, and Type 2 DM and prediabetes mononuclear
leukocyte cells (MNC) were thawed on the scheduled date
of the study and then washed with phosphate buffered
saline (PBS). MNC samples were homogenized in SONICS
VC-505 ultrasonic homogenizer (Sonics & Materials,
Inc. USA) at 100 hertz for 5 min, and then the intended
parameters were studied.
After the cells were completely lysed, citrate levels from
the released MNC content were manually studied, and
lactate levels were applied to the RANDOX Lactate Kit
Olympus AU 400 autoanalyzer (Olympus Corporation).
Lactate and citrate results were calculated as µg/mL.
Researchers had no information about which group the
samples belonged to until the concrete data was obtained
from the study.
At the beginning of the study, it was planned to take
the samples into fluoride tubes for the inhibition of
glycolytic enzymes from the time of collection, to keep the
current substrate levels of the cells constant and to ensure
the necessary enzyme inhibition (with HCl) until the
measurement time in leukocyte suspension after leukocyte
separation. The rate of metabolism was evaluated using
lactate levels for anaerobic glycolysis and citrate levels for
aerobic glycolysis.
After the formation of pentabromo acetoneas result of
oxidation and bromination of citric acid, modified Cahors
method based on spectrophotometric measurement was
used for the measurement of Citrate levels in mononuclear
leukocyte.
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2.1. Statistical analysis
SPSS 15.0 software for Windows (SPSSInc., Chicago, IL,
USA) was used for statistical analysis. Frequency Tables
are presented for categorical variables, and descriptive
statistics (mean, std. Deviation, minimum, maximum)
are presented for numerical variables. The comparison of
continouos variables among four groups were done with
Kruskall-Wallis test and the binary comparisons were done
with Mann-Whitney u test with Bonferroni correction. In
binary comparisons, according to Bonferroni correction,
P value <0.008 accepted as statistically significant. The
categorical variables were compared with Chi-square
test. The correlation analysis was done with spearman
correlation test.

in NDDP group, and the highest HDL level was noted
in the healthy control group. There was no significant
difference between the groups in terms of HDL levels.
The highest LDL level was noted in NDDP group and
the lowest LDL level was noted in IGT group. There was
no statistically significant difference between the groups
in terms of LDL levels. Body mass index (BMI) was the
highest in IGT group. There was a significant difference
between the controls and the NDDP, IFG, and IGT groups
in terms of BMI, detailed in Table 1.
Mean fasting blood glucose (FBG) levels were noted as
175.57 ± 62.72 mg/dL in the NDDP group, 106.57 ± 5.14
mg/dL in the IFG group, 100.14 ± 12.41 mg/dL in the IGT
group and 89.32 ± 6.96 in the control group. There was a
significant difference between the controls and the NDDP,
IFG and IGT groups in terms of FBG levels (P < 0.001, P <
0.001 and P < 0.001, respectively). FBG levels were found
to be significantly lower in controls compared to the other
groups. Mean FBG levels were found to be significantly
higher in the NDDP group.
Postprandial blood glucose (PBG) levels were noted
as 218.71 ± 84.42 mg/dL in NDDP patients, 151.53 ±
7.78 mg/dL in IGT patients, 102.83 ± 0.82 mg/dL in IFG
patients, and 85 ± 21.41 mg/dL in control patients. There
was a significant difference between the groups in terms of
PBG levels. Mean PBG levels were found to be significantly
higher in the NDDP group (P < 0.001). IGT patients had
significantly higher PBG levels compared to IFG patients
(P < 0.001). IFG and IGT patients had significantly higher
PBG levels compared to the control group (P = 0.009 and
P < 0.001, respectively).
Mean HbA1c levels were noted as 8.18% ± 2.48% in
NDDP patients, 5.91% ± 0.5% in IGT patients, 5.91%
± 0.34% in IFG patients and 5.80% ± 0.32% in control

3. Results
There were 21 newly diagnosed diabetic patients (NDDP),
7 with impaired fasting glucose (IFG), 23 with impaired
glucose tolerance (IGT), and 22 healthy control volunteers
(CP). The study groups consisted of 44 (60.3%) females
and 29 (39.7%) males. There was no significant difference
between the groups in terms of sex. The groups were
similar in terms of sex, serum LDL, HDL, cholesterol, and
body fat percentage (BFP), detailed in Table 1.
The mean age was significantly higher in the NDDP
group compared to healthy controls. However, all other
groups were statistically similar in terms of mean age.
Among all groups, the highest triglyceride level was found
in the NDDP group. There was a statistically significant
difference between the NDDP group and the IFG and CP
groups in terms of triglyceride levels. The highest total
cholesterol level was found in the NDDP group. There was
no statistically significant difference between the groups in
terms of total cholesterol. The lowest HDL level was noted

Table 1. Mean values of demographic characteristics of the study groups.
Mean values

Control

NDDP

IFG

IGT

P

AGE (year)

41.95 ± 7.96

50.48 ± 8.75

47.39 ± 11.24

42.29 ± 10.04

0.03 a 0.128 b 0.798 c

LDL mg/dL

120.45 ± 43.77

130 ± 34.48

122.22 ± 32.65

110.14 ± 35.06

0.444 a 0.820 b 0.628 c

HDL mg/dL

49.68 ± 8.05

44.71 ± 10.79

49.87 ± 10.81

46 ± 10.93

0.145 a 0.820 b 0.230 c

Cholesterol mg/dL

196.18 ± 50.02

223.9 ± 35.95

198.26 ± 38.93

207.14 ± 32.66

0.078 a 0.937 b 0.308 c

Triglyceride mg/dL

129.64 ± 73.79

244 ± 183.68

143.96 ± 63.36

237.57 ± 114.13

0.001 a 0.192 b 0.008 c

BFC

29.7 ± 9.59

32.75 ± 8.73

34.32 ± 9.78

28.67 ± 12.82

0.325 a 0.089 b 0.980 c

BMI

26.10 ± 4.08

30.51 ± 5.06

29.72 ± 4.22

31.22 ± 3.67

0.004 a 0.007 b 0.008 c

BFC: body fat percentage.
BMI: body mass ındex.
a: control compared with NDDP.
b: control compared with IFG.
c: control compared with IGT.
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patients. Compared to the other groups, NDDP patients
had significantly higher HbA1c levels (P < 0.001). There
was no significant difference between the other groups
(IFG, IGT and CP) in terms of mean HbA1C levels.
Mean insulin levels were measured as 19.21 ± 14.7
mIU/mL in the NDDP group, 17.95 ± 7.80 mIU/mL in the
IGT group, 10.82 ± 4.45 mIU/mL in the IFG group and
11.87 ± 5.04 mIU/mL in the control group. There was only
a significant difference between the IFG and IGT groups.
The insulin resistance characteristics of the study
groups were evaluated. Insulin resistance levels were
found to be the highest (85.7%) in the NDDP group. It was
71.4% in IGT patients, 52.2% in IFG patients and 40.9% in
control patients. Insulin resistance levels of NDDP patients
were found to be significantly higher compared to IFG and
control patients (P = 0.017 and P = 0.002, respectively).
When the parameters examined for all groups are
evaluated. There was a significant correlation between
HbA1c and lactate levels (r = 0.246, P = 0.036) but there
was no significant correlation between HbA1c and citrate
levels (r = -0,121, P = 0,315). There was a significant
correlation between FPG and lactate levels (r = 0.245, P
= 0.037) but there was no significant correlation between
FPG and citrate levels. (r = -0.122, P = 0.302). There was
no significant correlation between PPG, lactate (r = 0.179,
P = 0.129) and citrate levels (r = -0.083, P = 0.483). There
was no significant correlation between insulin, lactate (r =
-0.152, P = 0.199) and citrate levels (r = -0.028, P = 0.813).
There was no significant correlation between insulin
resistance, lactate (r = -0.103, P = 0.388), and citrate levels
(r = -0.076, P = 0.520). Comparisons of lactate and citrate
levels were detailed in Table 2.
Our study showed that there was a positive significant
correlation between HbA1c and FBG levels (r = 0.902, P <
0.001), postprandial BG levels (r = 0.841, P < 0.001), lactate
levels (r = 0.246, P = 0.036), (Figure 1), insulin resistance
(r = 0,243, P = 0.039), serum cholesterol levels (r = 0.264,
P = 0.024) and triglyceride levels (r = 0.324, P = 0.005).
However, when the groups were examined separately,
there was a statistically significant positive correlation
between HbA1c levels and FBG levels, postprandial BG
levels, and lactate production in the NDDP group. There
was no correlation between HbA1c and citrate production.
When all groups were examined separately, the correlation

between FBG levels and lactate production increased only
in the NDDP group (r = 0.610, P = 0.003), (Figure 2).
4. Discussion
The end product of glycolysis is pyruvate in cells with
mitochondria and enough oxygen. In the absence of
sufficient oxygen, glucose turns into lactate. Pyruvate,
the final product of pyruvate dehydrogenase glycolysis,
converts irreversibly into acetylCoA, the basic fuel of citric
acid cycle and the building block of fatty acid synthesis
[8]. Lactic acidosis is caused by a number of reasons,
including pyruvate dehydrogenase deficiency [9]. Pyruvate
dehydrogenase activity in the lymphocytes of patients
with type 2 diabetes mellitus (type 2 DM) is less compared
to healthy patients [10, 11]. It can be used in glucose,
glycolysis or oxidative phosphorylation for the production
of adenosine triphosphate (ATP) [12]. Glycolysis occurs
in cytosoland 2 molecules of pyruvate are formed from
1 molecule of glucose. 2 ATPs are obtained from each
molecule of glucose and oxygen is independent. The
pyruvate is converted to lactate and nicotinamide adenine
dinucleotide (NADH) is re-oxidized to form nicotinamide
adenine dinucleotide (NAD). Alternatively, oxidative
phosphorylation is oxygen dependent and occurs in
mitochondria. It consists of two reactions: transformation
of intermediate molecules (pyruvate and fatty acid) to
Acetyl Coenzyme A (Acetyl CoA) and reduction of
acetyl CoA to carbondioxide (CO2) in the tricarboxylic
acid cycle. Free electrons are carried by NADH and the
reduced flavin adenine dinucleotide (FADH2). Electrons
are transferred to the electron transfer chain. It results
in the protons coming out of the mitochondrial matrix.
This electrochemical potential is used in the production
of ATP with ATP synthase, and a net 30-32 ATP is gained
for each glucose. In this case, oxidative phosphorylation is
seen to be more efficient in ATP production. In this study,
we investigated the shift of the energy metabolism in the
neutrophils of diabetic patients to the aerobic or anaerobic
direction.
Studies focused on the immune response in diabetics
first began to be reported in the 1960s. Then, it was shown
that impaired PMNL chemotaxis during ketoacidosis
reached normal levels as ketoacidosis improved. In
the early 1970s, Mowat and Baum showed that in in

Table 2. Comparisons of the mean lactate and citrate levels of the groups.
Control

NDDP

IFG

IGT

P

Lactate µg/mL

0.212 ± 0.147

0.236 ± 0.204

0.246 ± 0.215

0.214 ± 0.206

0.950

Citrate µg/mL

82.28 ± 20.09

78.41 ± 15.60

79.53 ± 18.41

79.23 ± 16.56

0.974

NDDP: newly diagnosed diabetes patients; IFG: impaired fasting glucose, IGT: ımpaired glucose tolerance.
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Figure 1. Relationship between the HbA1 levels and lactate
production.

vitro conditions, PMNL chemotaxis index was low in
diabetic patients [13]. Molenaar et al. showed that PMNL
chemotaxis index was impaired in the first-degree relatives
of diabetic patients [14]. Alexiewicz et al. reported that
the ability of phagocytosis in PMNL obtained from newly
diagnosed type 2 diabetics decreased, which was related to
glycemic control, and that glycemic control obtained by a
3-month treatment also improved phagocytosis functions
[15].There are many disorders in the immune system of
diabetics; however, the most important factor causing
susceptibility to infections is the deterioration in leukocyte
functions [16].
It has been shown that various aspects of inflammation
are impaired in the process of diabetes [17]. Martin et
al. and Esman found a decrease in lactate production
in the neutrophils of diabetic cases [2,18]. In addition,
lactate production was found to be reduced by 24% when
compared to controls in the neutrophils of diabetic rats
[3]. In this study, we investigated the energy metabolism of
mononuclear leukocyte cells in prediabetics and patients
with Type 2 DM. When the groups were compared with
each other, no difference was found between citrate and
lactate values, indicating that there was no difference in
terms of the use of aerobic and anaerobic pathways in
leukocytes.
A statistically significant correlation was found
between HbA1c and FBG levels, postprandial BG levels,
lactate production, insulin resistance, serum cholesterol,
and triglyceride levels. However, when the groups were
analyzed separately, there was a statistically significant
positive correlation between HbA1c levels and FBG,
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Figure 2. The relationship between the FBG levels and lactate
production in NDDP group.

postprandial BG levels and lactate production only in the
NDDP group. However, there was no correlation between
HbA1c levels and citrate production. These findings
suggest that insulin resistance, FBG levels, postprandial
BG levels, and HbA1c values are more closely related
to metabolic status rather than the current diagnosis of
the patient. Insulin resistance, FBG, postprandial BG
levels, and HbA1c levels lead to an increase in anaerobic
respiration rather than aerobic respiration. It is true that
diabetic leukocytes use aerobic glycolysis, and this is
also valid for normal leukocytes. When compared with
normal leukocytes, the similarity in aerobic and anaerobic
metabolism of diabetic leukocytes does not indicate
that the energy metabolism is normal. Anaerobic lactate
production of diabetic leukocytes increases in the presence
of conditions such as increased insulin resistance, elevated
FBG levels, increased cholesterol levels, and high HbA1C
levels, indicating that diabetes becomes worse.
As our study does not include comparisons that show
the effect of environment variables, we can only estimate
the effect of storage conditions on the results. Nevertheless,
we can say that the stored samples were under anaerobic
conditions. The fetal bovine serum added to all samples
provides sufficient substrate for leukocyte cells.
The difference between the groups in terms of lactate
levels, widely accepted as an indicator of anaerobic pathway,
has been reported to be different in similar studies. Martin
et al. and Esman found a decrease in lactate production in
the neutrophils of diabetic cases [2,18].
In addition, lactate production was reduced by
24% when compared to controls in the neutrophils of
diabetic rats [3]. Şahin et al. found lactate production to
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be significantly higher in IGT and DM groups compared
to the leukocytes of healthy volunteers [6]. However, in
our study, lactate production was similar among groups,
whereas lactate production increased in diabetics.
There are many articles in the literature tackling
anaerobic and aerobic glycolysis in leukocytes. However,
it is very difficult to evaluate them together due to
differences in the procedures in these studies. Glycolytic
pathway enzymes were compared to determine metabolic
differences, and effective results could not be reached by
different researchers, since the studies did not continue in
the same direction. Numerous tissue studies on glycolysis
have focused on different reactions in glycolysis but there
is no answer to the question of whether these rates are
constant values in the same disease groups as metabolic
indicators.
ATP-ADP ratios are also studied parameters to obtain
a constant value. The variability of the multifactors
(appropriate pH, thermodynamic state, low apoenzyme
concentration, activator-coenzyme deficiency, etc.) that
determine the effect of enzymes in the glycolytic pathway in
different tissues rendered these classifications ineffective.
Providing the Michael constants (substrate, coenzyme,
optimal pH, etc.) to the same degree made it possible to
compare different samples, and the determination of
glycolytic ratios by kinetic enzyme studies may determine
whether the hypotheses put forward are correct. We used
the substrate instead of the enzyme for the same purpose.
Our disadvantage was that the same samples could not
be studied under different influences. We used all viable
inanimate cells when comparing substrate levels. The
metabolism of cells was slowed/stopped until study time.
Lactate and citrate levels were compared with those of
the controls only once. Therefore, we could not comment
on the amount of change. The absence of difference
compared to healthy cells indicates that there was no
difference between aerobic and anaerobic pathways.
Lymphomononuclear (LMN) cells alter energy metabolism
in the hyperglycemic state and shift to the anaerobic
glycolysis pathway. The changing glycolytic pathway may
affect the response of these cells to the immune stimulus
[19-22]. It has been previously reported that LMN cells
cannot effectively oxidize glucose in diabetic conditions,
lymphocytes obtained from diabetic rats show decreased
hexokinase and citrate synthase activity [23].
It has been previously shown that lactate production
was significantly higher in DM and IGT groups compared
to healthy controls. There was no significant difference
between DM and IGT groups in our study. It is thought that
the prediabetic stage may alter the cell energy metabolism.
It has also been reported that the oxidation ability of
lymphocytes is impaired due to high glucose levels [6].

In our study, a positive correlation was found between
high blood sugar and lactate production. Similar results
were reported in a study of streptozotocin-induced
diabetic rat thymus lymphocytes [24]. It has been reported
that lymphocytes and neutrophils use anaerobic glycolytic
pathways in experimental diabetic models. Aerobic
glycolysis increases after insulin treatment [3].
In this study, we tried to determine the effect of high
glucose concentrations on leukocyte functions. The
presence of insulin receptors in monocytes has previously
been shown [25]. Insulin resistance may have a direct role
in decreased LMN cell functions, and increased lactate may
also play a role in insulin resistance and the development of
diabetes [26].The relationship between lactate production
and blood glucose levels in our study suggests a similar
situation. Although there was no significant difference
between lactate and citrate levels between the groups in
our study, the correlation between blood sugar and lactate
levels was striking, and this shows the importance of blood
sugar control. The Diabetes Control and Complications
Trial (DCCT) and the UK Prospective Diabetes Study
(UKPDS) indicate that the same effort should be made
for glycemic control in DM and IGT cases [27-29]. In the
present study, there was no significant difference in the
energy metabolism of diabetic, prediabetic, and normal
leukocytes but the anaerobic glycolytic pathway correlated
with glucose levels. This shows the importance of blood
sugar regulation to prevent infection. Currently, studies on
glucose metabolism, which play a key role in infections in
diabetic patients, remains important. Glucose metabolism
in all cells is the common pathway used to maintain cell
continuity. The difference between diabetic leukocytes
and normal leukocytes is the reason of the increased use
of anaerobic glycolytic pathway in parallel with increased
blood glucose.
Our study has the following limitations. Firstly, our
NDDP group is older than the remaining groups. It is
known that aging is a main influencer on immune system
function. Secondly, insulin resistance rate of control group
is 40.9%.
In conclusion, this study is one of the rare studies
investigating the metabolic effects of hyperglycemia on
leukocytes. LMN cells follow similar metabolic pathways
in diabetic, prediabetic, and control groups, the difference
being the increased anaerobic pathway, which positively
correlates with blood glucose levels and insulin resistance.
This adaptation mechanism begins before the
emergence of diabetes. Further studies on this subject with
larger groups are required to enlighten the mechanisms
affecting the relation between diabetes and immune
response.
In addition, a wide age range was determined in our
study. It is known that with increasing age, his immunity
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decreases. New studies with a narrower age range are
needed to support our findings.
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